Yuka Hirayama1、Kakeru Sato1,2、Asuka Mizutani3、Masato Kobayashi3、Keiichi Kawai3,4 (1.The University of Kanazawa, Kanazawa, Japan、2.Department of Radiology, University of Fukui Hospital, Fukui, Japan、3.Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan、4.Biomedical Imaging Research Center, Fukui University, Fukui, Japan)
Session information
[JSNM]Oral
Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題
Oral 36:Chemistry 4
Sat. Nov 9, 2024 8:30 AM - 9:30 AM Room 3 (5F 511+512, Conference Center, PACIFICO Yokohama)
座長:小野 正博(京都大学大学院薬学研究科 病態機能分析学分野)、山口 博司(藤田医科大学病院)
Tomoya Fukada、Kohei Sano、Momoka Nakata、Toshihide Yamasaki、Takahiro Mukai (Laboratory of Biophysical Chemistry, Kobe Pharmaceutical University, Kobe, Japan)
Masayuki Munekane1、Kazuki Matsunaga1、Miki Ozaki1、Kenji Mishiro2、Takeshi Fuchigami1、Kazuma Ogawa1,2 (1.Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan、2.Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan)
Akira Makino1、Hiroyuki Watanabe2、Tetsuya Mori1、Masahiro Ono2、Yasushi Kiyono1 (1.Biomedical Imaging Research Center, University of Fukui, Fukui, Japan、2.Graduate School of Pharmaceutical Sciences, Kyoto University)
Takayuki Ohkubo1,2、Lin Xie1、Masayuki Fujinaga1、Masayuki Hanyu1、Nobuki Nengaki1,2、Kazunori Kawamura1、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan)
Mizuho Yamasaki1、Kohei Sano1、Airi Sekito1、Toshihide Yamasaki1、Mai Hayakawa2、Daniel Citterio2、Yuki Hiruta2、Takahiro Mukai1 (1.Laboratory of Biophysical Chemistry, Kobe Pharmaceutical University, Kobe, Japan、2.Faculty of Science and Technology, Keio University, Kanagawa, Japan)